Merck Acquires Curon's Bispecific Antibody for $1.3 Billion
Aug 13, 2024
Antibody Invest Information
Pasithea Therapeutics Advances ALS Treatment with New Lead Candidate PAS-003 Targeting α5β1 Integrin
Nov 9, 2023